Biora Therapeutics, Inc.
TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH GLATIRAMER OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF

Last updated:

Abstract:

This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with glatiramer or a pharmaceutically acceptable salt thereof, such as glatiramer acetate).

Status:
Application
Type:

Utility

Filling date:

13 Aug 2018

Issue date:

1 Oct 2020